ALFA Filings
Every announcement, straight from the exchange
Every Nath Bio-Genes (India) other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Nath Bio-Genes (India) Limited filed the Compliance Certificate for the quarter ended September 30, 2026, as required under Regulation 74(5) of the SEBI regulations.
Nath Bio-Genes (India) Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This disclosure provides the updated distribution of shareholding across various investor categories.
Nath Bio-Genes (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The auditor reported nil non-compliance, confirming the company's strong governance standards.
Nath Bio-Genes (India) Ltd confirmed it is not a Large Corporate under SEBI norms. The company reported zero outstanding long-term borrowings as of March 2026.